Two days after the initial downgrade-driven selloff, MANH is throwing up a genuinely contradictory picture. Short sellers are adding, options traders are buying calls, and retail attention has spiked to its highest point in months.
Wikipedia views and ORTEX page traffic for Manhattan Associates hit 3.4 standard deviations above their own 90-day history as of September 27. That is a notable spike in retail attention, though ORTEX flags this as an attention measure, not a revenue or earnings indicator.
The timing matters. The stock is down 10.4% over the past month and is trading at $200.11. A drawdown of that size on a stock previously known for its premium valuation tends to attract new eyes.
The data is pulling in opposite directions right now.
Short interest sits at 5.4% of free float, up 24% over the past month and up 12.3% in the past week alone. That is the highest level in months, and the accumulation has been fast. The prior convergence report on September 28 covered the DA Davidson downgrade that accompanied the initial surge. Since then, shorts have continued adding despite the stock dropping a further 0.9% on September 29.
The borrow market remains loose. Availability stands at 1,498%, meaning there are roughly 15 shares available for every one already borrowed. Cost to borrow is at 0.48%, down 11% on the week. There is no sign of a supply squeeze that would hurt the short trade mechanically.
Options traders are reading this differently. The put-call ratio fell to 0.787 on September 29, sitting 1.77 standard deviations below its 20-day mean of 0.956. That is persistent call-buying pressure. The PCR has been falling steadily since mid-September, when it was above 1.03.
The broader analyst consensus remains Buy, with six Buy ratings against three Hold. DA Davidson's Clark Wright downgraded to Neutral on September 28, maintaining a $210 target. That $210 is now only 5% above the current price, while Baird's Joe Vruwink holds an Outperform with a $260 target and Barclays' Guy Hardwick sits at Overweight with $239.
The bull case, per Benzinga's framing, rests on cloud subscription revenue up 24% year-on-year, total RPO growth of 24%, and a 32.4% non-GAAP operating margin. The bear case centres on an updated guidance range that may already reflect the good news, with the full-year guide implying only 7% revenue growth at the midpoint.
Earnings are due on October 20, 20 days away. The last print on July 28 produced a 28% single-day move. The one before that, on July 21, saw the stock fall 9.9%.
See the live data behind this article on ORTEX.
Open MANH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
